Collagenous colitis in systemic sclerosis: An overlooked and treatable complication

Journal of Clinical Rheumatology

Volumn 20, Issue 5, 2014, Pages 278-282

  Abignano, Giuseppina ^a,b   Scott, Nigel ^b   Wollheim, Frank A ^c   Emery, Paul ^a,b   Buch, Maya H ^a,b   Del Galdo, Francesco ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Allograft inflammatory factor 1; Caveolin 1; Chronic diarrhea; Collagenous colitis; Intestinal disease; Scleroderma; Systemic sclerosis

Indexed keywords

ACETYLSALICYLIC ACID; ALLOGRAFT INFLAMMATORY FACTOR 1; BUDESONIDE; CAVEOLIN 1; COLLAGEN; LANSOPRAZOLE; NIFEDIPINE; PROSTANOID; RABEPRAZOLE;

ABDOMEN; ABDOMINAL CRAMP; ABDOMINAL PAIN; AGED; ARTICLE; BARIUM ENEMA; BLOATING; BLOOD CELL COUNT; CASE REPORT; COLLAGENOUS COLITIS; COLON BIOPSY; COLON DIVERTICULOSIS; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DIETITIAN; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DUODENITIS; ENDOSCOPY; FEMALE; FINGER ULCER; GASTRITIS; GENERAL PRACTITIONER; HISTOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IRRITABLE COLON; LIVER FUNCTION TEST; MEDICAL HISTORY; PATHOGENESIS; PELVIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAYNAUD PHENOMENON; REFLUX ESOPHAGITIS; SIGMOID; STAINING; SYSTEMIC SCLEROSIS; TELANGIECTASIA; THYROID FUNCTION TEST; WEIGHT REDUCTION; COLITIS, COLLAGENOUS; COMPLICATION; DRUG ADMINISTRATION; FOLLOW UP; NEEDLE BIOPSY; PROCEDURES; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

AGED; BIOPSY, NEEDLE; BUDESONIDE; COLITIS, COLLAGENOUS; COLONOSCOPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LANSOPRAZOLE; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84905123464     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0000000000000121     Document Type: Article

References (29)

1. Lindström CG. 'Collagenous colitis' with watery diarrhoeaVa new entity?. Pathol Eur. 1976;11:87-89.
2. Bohr J, Olesen M, Tysk C, et al. Collagenous colitis and lymphocytic colitis: A clinical and histopathological review. Can J Gastroenterol. 2000;14:943-947.
3. Münch A, Aust D, Bohr J, et al. Microscopic colitis: Current status, present and future challenges: Statements of the European Microscopic Colitis Group. J Crohns Colitis. 2012;6:932-945.
4. Wollheim FA. Collagenous colitis and rheumatology. Curr Rheumatol Rep. 2000;2:183-184.
5. Widgren S, Jlidi R, Cox JN. Collagenous colitis, histologic, morphometric, immunohistochemical and ultrastructural studies. Report of 21 cases. Virchows Arch Pathol Anat. 1988;413:287-296.
6. Esselinckx W, Bernard R, Colin JF, et al. Juvenile scleroderma and collagenous colitis. The first case. J Rheumatol. 1991;16:834-836.
7. Kenesi-Laurent M, Chapelon-Abric C, Fattah ZA, et al. The first case of CRST syndrome associated with collagenous colitis. J Rheumatol. 1991;18:1765-1767.
8. Bowling TE, Price AB, al-Adnani M, et al. Interchange between collagenous and lymphocytic colitis in severe disease with autoimmune associations requiring colectomy: A case report. Gut. 1996;38:788-791.
9. Ekiz F, Coban S, Savas B, et al. Collagenous colitis in a patient with systemic sclerosis: A rare entity. J Natl Med Assoc. 2007;99:681-682.
10. Gerth HU, Willeke P, Sunderkötter C, et al. Systemic sclerosis and collagenous colitis in a patient with retroperitoneal fibrosis. Scand J Rheumatol. 2011;40:322-323.
11. Taha Y, Raab Y, Larsson A, et al. Vascular endothelial growth factor (VEGF)Va possible mediator of inflammation and mucosal permeability in patients with collagenous colitis. Dig Dis Sci. 2004;49:109-115.
12. Günther U, Bateman AC, Beattie RM, et al. Connective tissue growth factor expression is increased in collagenous colitis and coeliac disease. Histopathology. 2010;57:427-3.
13. Del Galdo F, Maul GG, JimeAnez SA, et al. Expression of allograft inflammatory factor 1 in tissues from patients with systemic sclerosis and in vitro differential expression of its isoforms in response to transforming growth factor beta. Arthritis Rheum. 2006;54:2616-2625.
14. Del Galdo F, Sotgia F, de Almeida CJ, et al. Decreased expression of caveolin 1 in patients with systemic sclerosis: Crucial role in the pathogenesis of tissue fibrosis. Arthritis Rheum. 2008;58:2854-2865.
15. Bohr J, Tysk C, Eriksson S, et al. Collagenous colitis: A retrospective study of clinical presentation and treatment in 163 patients. Gut. 1996;39:846-851.
16. Olesen M, Eriksson S, Bohr J, et al. Microscopic colitis: A common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998. Gut. 2004;53:346-350.
17. Kitchen PA, Levi AJ, Domizio P, et al London Inflammatory Bowel Disease Forum. Microscopic colitis: The tip of the iceberg?. Eur J Gastroenterol Hepatol. 2002;14:1199-1204.
18. Thomson RD, Lestina LS, Bensen SP, et al. Lansoprazole-Associated microscopic colitis: A case series. Am J Gastroenterol. 2002;97:2908-2913.
19. Wilcox GM, Mattia AR. Microscopic colitis associated with omeprazole and esomeprazole exposure. J Clin Gastroenterol. 2009;43:551-553.
20. Wang XM, Zhang Y, Kim HP, et al. Caveolin-1: A critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med. 2006;203:2895-290.
21. Otieno FG, Lopez AM, Jimenez SA, et al. Allograft inflammatory factor-1 and tumor necrosis factor single nucleotide polymorphisms in systemic sclerosis. Tissue Antigens. 2007;69:583-591.
22. Alkassab F, Gourh P, Tan FK, et al. An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis. Rheumatology (Oxford). 2007;46:1248-1251.
23. Tan FK, Zhou X, Mayes MD, et al. Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford). 2006;45:694-702.
24. Milano A, Pendergrass SA, Sargent JL, et al. Molecular subsets in the gene expression signatures of scleroderma skin. PLoS One. 2008;3:e2696.
25. Baert F, Schmit A, D'Haens G, et al. Budesonide in collagenous colitis: A double-blind placebo-controlled trial with histologic follow-up. Gastroenterology. 2002;122:20-25.
26. Miehlke S, Heymer P, Bethke B, et al. Budesonide treatment for collagenous colitis: A randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology. 2002;123:978-984.
27. Bonderup OK, Hansen JB, Birket-Smith L, et al. Budesonide treatment of collagenous colitis: A randomised, double blind, placebo controlled trial with morphometric analysis. Gut. 2003;52:248-251.
28. Miehlke S, Madisch A, Bethke B, et al. Oral budesonide for maintenance treatment of collagenous colitis: A randomized, double-blind, placebo-controlled trial. Gastroenterology. 2008;135:1510-1516.
29. Bonderup OK, Hansen JB, Teglbjaerg PS, et al. Long-Term budesonide treatment of collagenous colitis: A randomised, double-blind, placebo-controlled trial. Gut. 2009;58:68-72.